- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Hyperoxaluria Type 1 in Canada
Total 1062 results
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Cancer Research SocietyRecruitingNon-Muscle Invasive Bladder CancerCanada
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
University Health Network, TorontoCompletedPlatinum-resistant Epithelial Ovarian CancerCanada
-
University of AlbertaSuspended
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)CompletedCervical Cancer | Precancerous ConditionCanada
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)WithdrawnCervical Cancer | Precancerous ConditionCanada
-
University Health Network, TorontoCompletedStage IV Ovarian Cancer | Stage III Ovarian CancerCanada
-
University of British ColumbiaCompleted
-
Pharnext S.C.A.Premier Research Group plc; Eurofins Optimed; Synteract HCR (Syneos Health); Gr... and other collaboratorsActive, not recruitingCharcot-Marie-Tooth Disease, Type IAUnited States, Belgium, Canada, France, Netherlands, Spain, United Kingdom
-
NCIC Clinical Trials GroupCompletedProstate Cancer | Precancerous/Nonmalignant ConditionCanada
-
PfizerTerminatedDiabetes Mellitus, Type 1Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
-
Sunnybrook Health Sciences CentreJuravinski Cancer CenterActive, not recruiting
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
McGill UniversityRecruiting
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
Corporacion Parc TauliUnknownRenal Cell Carcinoma | Progression | Lymphocyte Disorder | Monocytosis | Local DiseaseSpain
-
University Health Network, TorontoRecruitingEndometrial Carcinoma | P53 Mutation | Serous CarcinomaCanada
-
University Health Network, TorontoUniversity of AmsterdamRecruitingMelanoma | Kidney Cancer | Head and Neck Cancer | NSCLC | Urothelial CarcinomaCanada
-
London Health Sciences CentreCanadian Institutes of Health Research (CIHR); The Kidney Foundation of CanadaCompletedMultiple Myeloma | Acute Renal FailureCanada
-
Lawson Health Research InstituteHamilton Health Sciences Corporation; London Health Sciences CentreCompletedClear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial CellsCanada
-
University of British ColumbiaBritish Columbia Cancer Agency; Women's Health Research Institute of British...CompletedUterine Cervical Dysplasia | Uterine Cervix CancerCanada
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, Canada, Croatia, Hungary, India
-
Western UniversityRecruitingMetastatic Clear Cell Renal Cell CarcinomaCanada
-
British Columbia Cancer AgencyUniversity of Victoria; University of Texas Southwestern Medical Center; Van...RecruitingOvarian Cancer | AscitesCanada
-
British Columbia Cancer AgencyCarraressi Foundation OVCARETerminatedOvarian Neoplasms | Ovarian CancerCanada
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Cancer | Stage IVB Cervical Cancer | Cervical Adenosquamous Cell CarcinomaCanada
-
Hamilton Health Sciences CorporationJuravinski Cancer Centre FoundationRecruitingMelanoma | Renal Cell Carcinoma | Breast Cancer | Prostate Cancer | Bone MetastasesCanada
-
AHS Cancer Control AlbertaTerminatedRenal Cell Carcinoma | Neuroendocrine TumoursCanada
-
Lawson Health Research InstituteCompletedTransitional Cell Carcinoma | Renal Cell Cancer | Testicular CancerCanada
-
PfizerTerminatedDiabetes Mellitus, Type 1United States, Canada, Brazil, Mexico, Argentina
-
Gilead SciencesActive, not recruitingPre-Exposure Prophylaxis of HIV-1 InfectionUnited States, Austria, Denmark, United Kingdom, Netherlands, Italy, Germany, Canada, Ireland, France, Spain
-
British Columbia Cancer AgencyCanadian Cancer Trials Group; Australia New Zealand Gynaecological Oncology... and other collaboratorsNot yet recruiting
-
GynesonicsWithdrawnLeiomyoma | Uterine Fibroids | MenorrhagiaCanada
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland
-
University Health Network, TorontoActive, not recruitingOvarian Cancer | Small Cell Carcinoma, Hypercalcaemic TypeCanada
-
University Health Network, TorontoTerminated
-
Andrea McCartOntario Institute for Cancer ResearchWithdrawn
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)Recruiting
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
PfizerNo longer availableRenal Cell CarcinomaAustralia, Canada
-
University Health Network, TorontoCompletedOvarian Cancer | Steroid Cell Tumor, MalignantCanada
-
Sunnybrook Health Sciences CentreMerck Canada Inc.Active, not recruitingHSIL, High-Grade Squamous Intraepithelial Lesions | Adenocarcinoma in Situ | Early Cervical CancerCanada
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1United States, France, Spain, Canada, South Africa, Argentina, Brazil, Romania
-
Cell GenesysUnknownCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States, Canada
-
Bernie EiglLady Davis Institute; Vancouver Prostate Centre; Bladder Cancer CanadaRecruitingMetastatic Urothelial Carcinoma | Metastatic Bladder CancerCanada
-
University Health Network, TorontoRecruitingCancer | Breast Cancer | Colorectal Cancer | Non-small Cell Lung Cancer | Melanoma (Skin) | Genitourinary Cancer | Gynecological Cancer | Rare Cancer | Carcinoma of Unknown Primary | Pancreatobiliary Gastrointestinal Cancer | Upper Aerodigestive Tract CancerCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCervical CancerUnited States, Canada
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus - Type 1United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, Chile, Malaysia, Panama, Romania, South Africa, Thailand, Brazil, Puerto Rico, Austria, Hungary, Australia, Guatemala
-
Novo Nordisk A/STerminatedDiabetes | Diabetes Mellitus, Type 1United States, Canada